Delayed graft function
Clinical trials for Delayed graft function explained in plain language.
Never miss a new study
Get alerted when new Delayed graft function trials appear
Sign up with your email to follow new studies for Delayed graft function, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Which diuretic protects a new kidney best? a Head-to-Head trial puts furosemide and mannitol to the test
Disease control Recruiting nowThis trial compares two common diuretics—furosemide and mannitol—given during kidney transplant surgery to see which better prevents delayed graft function, a condition where the new kidney does not work right away and requires dialysis. The study enrolls adults receiving a decea…
Matched conditions: DELAYED GRAFT FUNCTION
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug aims to kickstart transplanted kidneys faster
Disease control Recruiting nowThis phase 3 trial tests whether ravulizumab, given intravenously, can reduce the severity of delayed graft function (DGF) in adults at high risk after kidney transplant. DGF is when the new kidney is slow to start working, often requiring dialysis. The study will compare ravuliz…
Matched conditions: DELAYED GRAFT FUNCTION
Phase 3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a 2-Day infusion save transplanted kidneys from early damage?
Disease control Recruiting nowThis study tests whether a drug called treprostinil can help prevent injury to a new kidney during transplant surgery. About 20 adults receiving a deceased donor kidney will get the drug through an IV for two days, starting just before surgery. The goal is to see if it improves b…
Matched conditions: DELAYED GRAFT FUNCTION
Phase 1/2 • Sponsor: Rhode Island Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a common acid blocker save transplanted kidneys?
Disease control Recruiting nowThis early-phase trial tests whether a stomach acid drug called vonoprazan fumarate can reduce delayed graft function, a common complication where a new kidney doesn't work right away. About 47 first-time kidney transplant recipients will take the drug for seven days after surger…
Matched conditions: DELAYED GRAFT FUNCTION
Phase 1/2 • Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC